Dr Mina Kim has been awarded £2.1 million in a Career Development Award from the Medical Research Council, which forms part of the UK Research and Innovation (UKRI), to support her innovative work in advancing lung functional MRI for various chronic lung diseases (CLDs). Additionally, with support from a Cystic Fibrosis Trust Venture and Innovation Award grant, the studies will be extended to monitor changes in lung function over time in people with Cystic Fibrosis (CF).
The main aim of Dr Kim's research programme is to pioneer new MRI measurements that can accurately identify and track CLDs using novel oxygen-enhanced MRI methods which are safe and practical for use in clinical settings. To achieve this, she will collaborate with leading experts from prestigious institutions including UCL Centre for Medical Image Computing (CMIC), UCL Respiratory Medicine, University of Iowa, University of Pennsylvania, University of Sheffield, University College London Hospital (UCLH), and Royal Brompton Hospital. Additionally, she will engage with patient representative groups from two charities, Cystic Fibrosis Trust and Breathing Matters, ensuring the seamless integration of patient needs into the research studies.
I’m delighted to have received the fellowship and I’m looking forward to developing sensitive MRI biomarkers for subtle functional changes in the lungs, both in healthy ageing and chronic lung diseases. My team of multi-disciplinary and international collaborators will focus on technical method development and rigorous evaluation of its efficacy using preclinical and clinical models. Our ultimate goal is to translate these advancements into clinical practice, benefiting the millions worldwide affected by chronic lung diseases. We hope that this innovative MRI method will improve healthcare by facilitating more precise treatment timing and personalised therapy plans tailored to individual patients.Dr Mina Kim, Senior Research Associate
Director's Summer Reading List 2025
Recommendations for your Summer reading from IGP's Director, Professor Henrietta L. Moore.
23 Jun 2025
Digital Transformation in ATMP Manufacturing held at UCL East on 16 May
The event convened over 60 invited stakeholders across industry, NHS, academia, and regulation to address key barriers in the scaling of CAR-T and other advanced therapy medicinal products (ATMPs).
20 Jun 2025
New hub to harness the power of microbes to turn waste into valuable products
UCL Biochemical Engineering is part of a pioneering new hub that is set to transform UK manufacturing by converting industrial waste into valuable, sustainable chemicals and materials.
19 Jun 2025
